FDA Adverse Event Malfunction Summary report: N

DROPLET

MDR report key: 25134761 · Received May 11, 2026

Report

Report Number
3008272066-2026-00001
Event Type
Malfunction
Date Received
May 11, 2026
Date of Event
April 6, 2026
Report Date
May 11, 2026
Manufacturer
CHIRANA T. INJECTA, A.S.
Product Code
FMF
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING USE OF THE INSULIN SYRINGE, UPON ENGAGING THE SYRINGE, THE NEEDLE/CANNULA DISENGAGED FROM THE SYRINGE AND REMAINED IN THE PATIENT'S ARM. THE PATIENT EXPERIENCED PAIN ASSOCIATED WITH THE EVENT. THE NEEDLE/CANNULA WAS SUBSEQUENTLY REMOVED. NO ADDITIONAL INJURY OR MEDICAL INTERVENTION WAS REPORTED. THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE MANUFACTURING RECORDS FOR THE ASSOCIATED LOT/BATCH WAS PERFORMED AND NO DEVIATIONS OR NONCONFORMANCES WERE IDENTIFIED. REVIEW OF RETENTION SAMPLES DEMONSTRATED THAT THE SAMPLES MET RELEASE SPECIFICATIONS. BASED ON THE MANUFACTURING PROCESS AND CONTROLS, SEPARATION OF THE CANNULA FROM THE SYRINGE WOULD REQUIRE MULTIPLE INDEPENDENT MANUFACTURING FAILURES. NO EVIDENCE OF SUCH FAILURES WAS IDENTIFIED DURING REVIEW OF MANUFACTURING RECORDS OR TESTING. THE REPORTED FAILURE MODE COULD NOT BE CONFIRMED AND THE ROOT CAUSE COULD NOT BE DETERMINED. ALTHOUGH A MANUFACTURING-RELATED ISSUE COULD NOT BE CONFIRMED, IT COULD NOT BE CONCLUSIVELY RULED OUT. THE COMPLAINT WILL BE MONITORED AND TRENDED IN ACCORDANCE WITH THE MANUFACTURER'S QUALITY SYSTEM REQUIREMENTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
48540 DROPLET INSULIN SYRINGE 31GX6MM, 0,5ML FMF CHIRANA T. INJECTA, A.S. 6220 25176/4603

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown